Immunogenicity of Recombinant Proteins Consisting of Plasmodium vivax Circumsporozoite Protein Allelic Variant-Derived Epitopes Fused with Salmonella enterica Serovar Typhimurium Flagellin

A Plasmodium falciparum circumsporozoite protein (CSP)-based recombinant fusion vaccine is the first malaria vaccine to reach phase III clinical trials. Resistance to infection correlated with the production of antibodies to the immunodominant central repeat region of the CSP. In contrast to P. falc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Leal, Monica Teixeira Andrade, Camacho, Ariane Guglielmi Ariza, Teixeira, Laís Helena, Bargieri, Daniel Youssef, Soares, Irene Silva, Tararam, Cibele Aparecida, Rodrigues, Mauricio M.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2013
Matèries:
Vaccines
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3889588/
https://ncbi.nlm.nih.gov/pubmed/23863502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00312-13
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars